About this Journal Submit a Manuscript Table of Contents
Arthritis
Volume 2011 (2011), Article ID 203901, 8 pages
http://dx.doi.org/10.1155/2011/203901
Review Article

Adipokines and Osteoarthritis: Novel Molecules Involved in the Pathogenesis and Progression of Disease

SERGAS, NEIRID Lab (Laboratory of NeuroEndocrine Interaction in Rheumatology and Inflammatory Diseases), Institute of Medical Research (IDIS), Santiago University Clinical Hospital Building C, Level-2, 15706 Santiago de Compostela, Spain

Received 6 May 2011; Accepted 10 June 2011

Academic Editor: Hiroshi Kawaguchi

Copyright © 2011 Javier Conde et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Conrozier, C. Chappuis-Cellier, M. Richard, P. Mathieu, S. Richard, and E. Vignon, “Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis,” Revue du Rhumatisme (English Edition), vol. 65, no. 12, pp. 759–765, 1998. View at Scopus
  2. T. D. Spector, D. J. Hart, D. Nandra et al., “Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease,” Arthritis and Rheumatism, vol. 40, no. 4, pp. 723–727, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. D. T. Felson, J. J. Anderson, A. Naimark, A. M. Walker, and R. F. Meenan, “Obesity and knee osteoarthritis. The Framingham Study,” Annals of Internal Medicine, vol. 109, no. 1, pp. 18–24, 1988. View at Scopus
  4. S. A. Oliveria, D. T. Felson, P. A. Cirillo, J. I. Reed, and A. M. Walker, “Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee,” Epidemiology, vol. 10, no. 2, pp. 161–166, 1999. View at Scopus
  5. W. J. Carman, M. Sowers, V. M. Hawthorne, and L. A. Weissfeld, “Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study,” American Journal of Epidemiology, vol. 139, no. 2, pp. 119–129, 1994. View at Scopus
  6. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Scopus
  7. G. Fantuzzi, “Adiponectin and inflammation: consensus and controversy,” Journal of Allergy and Clinical Immunology, vol. 121, no. 2, pp. 326–330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Conde, R. Gomez, G. Bianco et al., “Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes,” Annals of the Rheumatic Diseases, vol. 70, no. 3, pp. 551–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Gualillo, J. R. González-Juanatey, and F. Lago, “The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives,” Trends in Cardiovascular Medicine, vol. 17, no. 8, pp. 275–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, “Positional cloning of the mouse obese gene and its human homologue,” Nature, vol. 372, no. 6505, pp. 425–432, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. R. S. Ahlma, D. Prabakaran, C. Mantzoros et al., “Role of leptin in the neuroendocrine response to fasting,” Nature, vol. 382, no. 6588, pp. 250–252, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Gualillo, S. Eiras, F. Lago, C. Diéguez, and F. F. Casanueva, “Elevated serum leptin concentrations induced by experimental acute inflammation,” Life Sciences, vol. 67, no. 20, pp. 2433–2441, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Dumond, N. Presle, B. Terlain et al., “Evidence for a key role of leptin in osteoarthritis,” Arthritis and Rheumatism, vol. 48, no. 11, pp. 3118–3129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Otero, J. J. Gomez Reino, and O. Gualillo, “Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-γ in human chondrocytes and ATDC5 chondrogenic cells,” Arthritis and Rheumatism, vol. 48, no. 2, pp. 404–409, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Otero, R. Lago, F. Lago, J. J. Reino, and O. Gualillo, “Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1,” Arthritis Research & Therapy, vol. 7, no. 3, pp. R581–R591, 2005. View at Scopus
  16. É. Toussirot, G. Streit, and D. Wendling, “The contribution of adipose tissue and adipokines to inflammation in joint diseases,” Current Medicinal Chemistry, vol. 14, no. 10, pp. 1095–1100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Koskinen, K. Vuolteenaho, R. Nieminen, T. Moilanen, and E. Moilanen, “Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients,” Clinical and experimental rheumatology, vol. 29, no. 1, pp. 57–64, 2011.
  18. R. Gómez, M. Scotece, J. Conde, J. J. Gómez-Reino, F. Lago, and O. Gualillo, “Adiponectin and leptin increase IL-8 production in human chondrocytes,” Annals of the Rheumatic Diseases. In press. View at Publisher · View at Google Scholar
  19. J. P. Bao, W. P. Chen, J. Feng, P. F. Hu, Z. L. Shi, and L. D. Wu, “Leptin plays a catabolic role on articular cartilage,” Molecular Biology Reports, vol. 37, no. 7, pp. 3265–3272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. S. Mutabaruka, M. Aoulad Aissa, A. Delalandre, M. Lavigne, and D. Lajeunesse, “Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression,” Arthritis Research & Therapy, vol. 12, no. 1, article R20, 2010. View at Scopus
  21. T. Simopoulou, K. N. Malizos, D. Iliopoulos et al., “Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism,” Osteoarthritis and Cartilage, vol. 15, no. 8, pp. 872–883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. H. Ku, C. K. Lee, B. S. Joo et al., “Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis,” Clinical Rheumatology, vol. 28, no. 12, pp. 1431–1435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. M. Griffin, J. L. Huebner, V. B. Kraus, and F. Guilak, “Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis,” Arthritis and Rheumatism, vol. 60, no. 10, pp. 2935–2944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. A. Berry, S. W. Jones, F. M. Cicuttini, A. E. Wluka, and R. A. MacIewicz, “Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis,” Arthritis and Rheumatism, vol. 63, no. 3, pp. 700–707, 2011. View at Publisher · View at Google Scholar
  25. E. Yusuf, A. Ioan-Facsinay, J. Bijsterbosch et al., “Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis,” Annals of the Rheumatic Diseases, vol. 70, no. 7, pp. 1282–1284, 2011. View at Publisher · View at Google Scholar
  26. D. K. Oh, T. Ciaraldi, and R. R. Henry, “Adiponectin in health and disease,” Diabetes, Obesity and Metabolism, vol. 9, no. 3, pp. 282–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Matsuzawa, “Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, no. 1, pp. 35–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Lago, R. Gomez, M. Otero et al., “A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes,” Osteoarthritis and Cartilage, vol. 16, no. 9, pp. 1101–1109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. K.-M. Tong, C.-P. Chen, K.-C. Huang et al., “Adiponectin increases MMP-3 expression in human chondrocytes through adipor1 signaling pathway,” Journal of Cellular Biochemistry, vol. 112, no. 5, pp. 1431–1440, 2011. View at Publisher · View at Google Scholar
  31. E. H. Kang, Y. J. Lee, T. K. Kim et al., “Adiponectin is a potential catabolic mediator in osteoarthritis cartilage,” Arthritis Research & Therapy, vol. 12, article R231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. H. Tang, Y. C. Chiu, T. W. Tan, R. S. Yang, and W. M. Fu, “Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-κB pathway,” Journal of Immunology, vol. 179, no. 8, pp. 5483–5492, 2007. View at Scopus
  33. K. W. Frommer, B. Zimmermann, F. M. P. Meier et al., “Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 62, no. 10, pp. 2886–2899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Filkova, M. Lišková, H. Hulejová et al., “Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis,” Annals of the Rheumatic Diseases, vol. 68, no. 2, pp. 295–296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Distel, T. Cadoudal, S. Durant, A. Poignard, X. Chevalier, and C. Benelli, “The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor,” Arthritis and Rheumatism, vol. 60, no. 11, pp. 3374–3377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. H. Chen, L. Chen, M. S. Hsieh, C. P. Chang, D. T. Chou, and S. H. Tsai, “Evidence for a protective role for adiponectin in osteoarthritis,” Biochimica et Biophysica Acta, vol. 1762, no. 8, pp. 711–718, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Uchida, K. Urabe, K. Naruse, Z. Ogawa, K. Mabuchi, and M. Itoman, “Hyperlipidemia and hyperinsulinemia in the spontaneous osteoarthritis mouse model, STR/Ort,” Experimental Animals, vol. 58, no. 2, pp. 181–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Honsawek and M. Chayanupatkul, “Correlation of plasma and synovial fluid adiponectin with knee osteoarthritis severity,” Archives of Medical Research, vol. 41, no. 8, pp. 593–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece, “Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor,” Molecular and Cellular Biology, vol. 14, no. 2, pp. 1431–1437, 1994. View at Scopus
  40. A. Fukuhara, M. Matsuda, M. Nishizawa et al., “Visfatin: a protein secreted by visceral fat that Mimics the effects of insulin,” Science, vol. 307, no. 5708, pp. 426–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Friebe, M. Neef, J. Kratzsch et al., “Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans,” Diabetologia, vol. 54, no. 5, pp. 1200–1211, 2011. View at Publisher · View at Google Scholar
  42. V. Catalán, J. Gómez-Ambrosi, A. Rodríguez et al., “Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 4, pp. 245–253, 2011. View at Publisher · View at Google Scholar
  43. C. A. Curat, V. Wegner, C. Sengenès et al., “Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin,” Diabetologia, vol. 49, no. 4, pp. 744–747, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Fukuhara, M. Matsuda, M. Nishizawa et al., “Retraction,” Science, vol. 318, no. 5850, p. 565, 2007. View at Scopus
  45. S. H. Jia, Y. Li, J. Parodo et al., “Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis,” Journal of Clinical Investigation, vol. 113, no. 9, pp. 1318–1327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. A. R. Moschen, A. Kaser, B. Enrich et al., “Visfatin, an adipocytokine with proinflammatory and immunomodulating properties,” Journal of Immunology, vol. 178, no. 3, pp. 1748–1758, 2007. View at Scopus
  47. M. Gosset, F. Berenbaum, C. Salvat et al., “Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis,” Arthritis and Rheumatism, vol. 58, no. 5, pp. 1399–1409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. I. R. Klein-Wieringa, M. Kloppenburg, Y. M. Bastiaansen-Jenniskens et al., “The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype,” Annals of the Rheumatic Diseases, vol. 70, no. 5, pp. 851–857, 2011. View at Publisher · View at Google Scholar
  49. Y. Duan, D. Hao, M. Li et al., “Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis,” Rheumatology International. In press. View at Publisher · View at Google Scholar
  50. C. M. Steppan and M. A. Lazar, “Resistin and obesity-associated insulin resistance,” Trends in Endocrinology and Metabolism, vol. 13, no. 1, pp. 18–23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Degawa-Yamauchi, J. E. Bovenkerk, B. E. Juliar et al., “Serum resistin (FIZZ3) protein is increased in obese humans,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5452–5455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. P. G. McTernan, C. L. McTernan, R. Chetty et al., “Increased resistin gene and protein expression in human abdominal adipose tissue,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2407–2410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. J. H. Lee, T. Ort, K. Ma et al., “Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro,” Osteoarthritis and Cartilage, vol. 17, no. 5, pp. 613–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Wittamer, J. D. Franssen, M. Vulcano et al., “Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids,” Journal of Experimental Medicine, vol. 198, no. 7, pp. 977–985, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. B. A. Zabel, S. J. Allen, P. Kulig et al., “Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades,” Journal of Biological Chemistry, vol. 280, no. 41, pp. 34661–34666, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Bozaoglu, K. Bolton, J. McMillan et al., “Chemerin is a novel adipokine associated with obesity and metabolic syndrome,” Endocrinology, vol. 148, no. 10, pp. 4687–4694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Luangsay, V. Wittamer, B. Bondue et al., “Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model,” Journal of Immunology, vol. 183, no. 10, pp. 6489–6499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Berg, B. Sveinbjornsson, S. Bendiksen, J. Brox, K. Meknas, and Y. Figenschau, “Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin21-157,” Arthritis Research & Therapy, vol. 12, no. 6, article R228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Triebel, J. Blaser, H. Reinke, and H. Tschesche, “A 25 kDa α2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase,” FEBS Letters, vol. 314, no. 3, pp. 386–388, 1992. View at Publisher · View at Google Scholar · View at Scopus
  60. V. Hvidberg, C. Jacobsen, R. K. Strong, J. B. Cowland, S. K. Moestrup, and N. Borregaard, “The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake,” FEBS Letters, vol. 579, no. 3, pp. 773–777, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. L. R. Devireddy, J. G. Teodoro, F. A. Richard, and M. R. Green, “Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation,” Science, vol. 293, no. 5531, pp. 829–834, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. S. T. Chu, H. J. Lin, H. L. Huang, and Y. H. Chen, “The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins,” Journal of Peptide Research, vol. 52, no. 5, pp. 390–397, 1998. View at Scopus
  63. J. B. Cowland and N. Borregaard, “Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans,” Genomics, vol. 45, no. 1, pp. 17–23, 1997. View at Publisher · View at Google Scholar · View at Scopus
  64. H. C. Owen, S. J. Roberts, S. F. Ahmed, and C. Farquharson, “Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes,” American Journal of Physiology, vol. 294, no. 6, pp. E1023–E1034, 2008. View at Publisher · View at Google Scholar
  65. K. Gupta, M. Shukla, J. B. Cowland, C. J. Malemud, and T. M. Haqqi, “Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9,” Arthritis and Rheumatism, vol. 56, no. 10, pp. 3326–3335, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. K. I. Yamamoto and S. Migita, “Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 9, pp. 2915–2919, 1985. View at Scopus
  67. C. A. Lowell, R. S. Stearman, and J. F. Morrow, “Transcriptional regulation of serum amyloid A gene expression,” Journal of Biological Chemistry, vol. 261, no. 18, pp. 8453–8461, 1986. View at Scopus
  68. M. C. De Beer, C. M. Beach, S. I. Shedlofsky, and F. C. De Beer, “Identification of a novel serum amyloid a protein in BALB/c mice,” Biochemical Journal, vol. 280, no. 1, pp. 45–49, 1991. View at Scopus
  69. B. Kluve-Beckerman, M. L. Drumm, and M. D. Benson, “Nonexpression of the human serum amyloid A three (SAA3) gene,” DNA and Cell Biology, vol. 10, no. 9, pp. 651–661, 1991. View at Scopus
  70. B. Kluve-Beckerman and M. Song, “Genes encoding human serum amyloid A proteins SAA1 and SAA2 are located 18 kb apart in opposite transcriptional orientations,” Gene, vol. 159, no. 2, pp. 289–290, 1995. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Lin, M. W. Rajala, J. P. Berger, D. E. Moller, N. Barzilai, and P. E. Scherer, “Hyperglycemia-induced production of acute phase reactants in adipose tissue,” Journal of Biological Chemistry, vol. 276, no. 45, pp. 42077–42083, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. H. Chang, S. Subramanian, C. K. Chan et al., “Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion,” Diabetes, vol. 56, no. 9, pp. 2260–2273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. J. C. Pickup, M. B. Mattock, G. D. Chusney, and D. Burt, “NIDDM as a disease of the innate immune system: association of acute- phase reactants and interleukin-6 with metabolic syndrome X,” Diabetologia, vol. 40, no. 11, pp. 1286–1292, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Vallon, F. Freuler, N. Desta-Tsedu et al., “Serum amyloid a (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases,” Journal of Immunology, vol. 166, no. 4, pp. 2801–2807, 2001. View at Scopus
  75. K. Hida, J. Wada, J. Eguchi et al., “Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 30, pp. 10610–10615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. C. M. De Souza Batista, R. Z. Yang, M. J. Lee et al., “Omentin plasma levels and gene expression are decreased in obesity,” Diabetes, vol. 56, no. 6, pp. 1655–1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Šenolt, M. Polanská, M. Filková et al., “Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 7, pp. 1410–1411, 2010. View at Publisher · View at Google Scholar